Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Journal of Market Access & Health Policy|July 29, 2024
Opportunities and Challenges in Cross-Country Collaboration: Insights from the Beneluxa InitiativeZilke Claessens, Michiel Lammens, Liese Barbier, et al.
BMC Health Services Research|February 22, 2023
Informing a European guidance framework on electronic informed consent in clinical research: a qualitative studyEvelien De Sutter, Pascal Borry, Isabelle Huys, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 3, 2020
European Stakeholder Learnings Regarding Biosimilars: Part I-Improving Biosimilar Understanding and AdoptionLiese Barbier, Steven Simoens, Arnold G Vulto, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 16, 2020
European Stakeholder Learnings Regarding Biosimilars: Part II-Improving Biosimilar Use in Clinical PracticeLiese Barbier, Steven Simoens, Arnold G Vulto, et al.
BMJ Open|January 9, 2025
Do European regulatory measures accelerate national market access in Belgium? A retrospective analysis of medicines centrally authorised between 2015 and 2020Zilke Claessens, Steffen Fieuws, Joël Daems, et al.
Frontiers in Pharmacology|July 29, 2022
Biosimilar Use and Switching in Belgium: Avenues for Integrated PolicymakingLiese Barbier, Steven Simoens, Paul Declerck, et al.
Expert Opinion on Biological Therapy|May 26, 2025
Evolving global regulatory landscape for approval of biosimilars: current challenges and opportunities for convergenceElif Car, Liese Barbier, Isabelle Huys, et al.
Applied Health Economics and Health Policy|April 19, 2025
Compulsory Licensing as an Instrument to Tackle High Medicine Prices: A Realist Review of Industrial and Health ConsequencesSteven Simoens, Walter Van Dyck, Rosanne Janssens, et al.
Frontiers in Medicine|January 22, 2025
Unmet medical needs definition and incentives: stakeholders perspectives on the reform of the EU pharmaceutical legislationIo Wens, Zilke Claessens, Alice Vanneste, et al.
Therapeutic Innovation & Regulatory Science|September 6, 2025
Future-Proofing European Pharmaceutical Regulatory and Market Access Practices Based on EU Learnings from the COVID-19 Pandemic: Insights from Multi-Stakeholder InterviewsZilke Claessens, Grace Beirne, Catherine Decouttere, et al.
Pageof 3